blank spaceblank spaceNational Research Council Canada / Conseil national de recherches Canadablank spaceGovernment of Canada
Skip all menus (access key: 2)Skip first menu (access key: 1)Menu (access key: M) Français Contact us Help Search Canada Site
BRI blank space Home Health Sector Bioprocess Sector Environment Sector NRC Site
Services Business Laboratory Space Publications Careers
Banner - Services
blank space Services Custom Antibodies Custom Peptides Resources Services Contact Us Protein Sequencing Flow Cytometry HTS MicroArray Microscopy and Imaging Animal Cell Pilot Plant Microbial Pilot Plant Mass Spectrometry Waste Biotreatability blank space

Custom Peptides

The mission of the BRI Custom Peptides Facility is to provide a high quality, customized and fully integrated peptide synthesis service to Canadian and international clients and partners.

Its experienced team has been producing and designing custom peptides for over 15 years and will meet the most demanding requirements. With its flexible platform which allows the production of peptides using chemical synthesis or recombinant technologies; the Facility can produce peptides without any length or sequence restrictions. The easily scalable recombinant technology together with the bioprocess platform offers cost-effective production of grams and kilograms of peptides, if required. BRI also offers a large array of other complementary expertise to develop peptide applications to their full potential.

Our Peptide Facility

Our Peptide Facility can produce long peptides (40-80 aa) through recombinant expression, using a patented technology developed by BRI.

Services highlights
The BRI Custom Peptides Facility offers:

  • Extensive expertise in peptide design
  • Synthetic or recombinant production
  • Crude or standard grades of purity (up to 99%)
  • Peptide amounts from milligrams to kilograms
  • Mass-spectrometry and HPLC analysis
  • Peptide modification and labeling
  • Guidance from BRI scientists regarding methodology of production, process optimization and peptide modifications
  • Access to the screening facility for testing bioactivity, target affinity or binding kinetics.
blank spaceFooter Line
Date Modified: 2005-08-31
Top of page